Juan Vera - 12 Feb 2025 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role: President and CEO, Director
Signature: /s/ Julio C. Esquivel, as Attorney-in-Fact for Juan Vera
Issuer symbol: MRKR
Transactions as of: 12 Feb 2025
Net transactions value: $0
Form type: 4
Filing time: 14 Feb 2025, 17:17:32 UTC
Previous filing: 07 Jun 2024
Next filing: 04 Nov 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRKR	Employee Stock Option (right to buy)	Award	$0	+50,000		$0.000000	50,000	12 Feb 2025	Common Stock	50,000	$1.59	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents options granted under the Company's 2020 Omnibus Stock Ownership Plan. One third of the shares vest on the first anniversary of the grant date and the remainder of the shares subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the closing price on the date of the grant, February 12, 2025.

Content

Represents options granted under the Company's 2020 Omnibus Stock Ownership Plan. One third of the shares vest on the first anniversary of the grant date and the remainder of the shares subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the closing price on the date of the grant, February 12, 2025.